Background
This meta-analysis aims to evaluate the utility of speckle tracking
echocardiography (STE) as a tool to evaluate for cardiac sarcoidosis
(CS) early in its course. Electrocardiography and echocardiography have
limited sensitivity in this role, while advanced imaging modalities such
as cardiac magnetic resonance (CMR) and 18F-Fluorodeoxyglucose–Positron
Emission Tomography (FDG-PET) are limited by cost and availability.